Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00743821 · ClinicalTrials.gov registry record

Eye-Tracking Rapid Attention Computation

A clinical trial, sponsored by Brain Trauma Foundation.

Completed
Registry status
426
Enrollment target

NCT00743821: Completed study, sponsored by Brain Trauma Foundation.

NCT00743821 is a clinical trial that has completed, run by Brain Trauma Foundation. The registered enrollment target is 426 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00743821 has completed, sponsored by Brain Trauma Foundation.

COMPLETED
Registry status
426 participants
Enrollment target

Study Summary

The purpose of this study is to validate and refine a diagnostic device that can detect attention and memory deficits that result from mild traumatic brain injury (mTBI).

Trial Details

FieldValue
Enrollment Target 426 participants
Start Date 2008-10
Est. Completion 2012-09
Brain Trauma Foundation

2 total trials

What the finished NCT00743821 record still lists

NCT00743821 is an observational study that tracks outcomes without assigning an intervention. The registered 426 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00743821 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00743821 about?

NCT00743821 is a clinical study titled "Eye-Tracking Rapid Attention Computation". The purpose of this study is to validate and refine a diagnostic device that can detect attention and memory deficits that result from mild traumatic brain injury (mTBI).

What is the current status of trial NCT00743821?

This trial is currently completed. The enrollment target is 426 participants. The study started on 2008-10. Estimated completion is 2012-09.

Who is sponsoring clinical trial NCT00743821?

This trial is sponsored by Brain Trauma Foundation, which has 2 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06790784 · 426 participants · Phase 3

    Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

  • NCT04265430 · 425 participants · Phase 4

    Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors

  • NCT04278690 · 425 participants · NA

    Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit

  • NCT05321368 · 425 participants · NA

    A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00743821, the US trial registry maintained by the National Library of Medicine. NCT00743821 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.